Axplora, a manufacturing partner for small-molecule active pharmaceutical ingredients (APIs) and antibody-drug conjugates, has announced that its greenhouse gas emissions-reduction targets have been validated by the Science Based Targets initiative.
ICS Cool Energy has completed successful field trials of its new autonomous cold storage unit, providing real-world validation of an integrated approach to off-grid temperature control.
Orbia Advance Corporation has received approval from the MHRA of Chiesi's Clenil Modulite (beclomethasone; 100 mcg and 200 mcg) inhaler formulated with Orbia F&EM’s next-generation, low-GWP propellant.
SGD Pharma has released its 2025 Sustainability Report detailing progress in its sustainable development journey and reinforcing its position at the forefront of environmental, social and ethical performance in the glass manufacturing industry
Tobias Lurk, global product performance manager at TÜV SÜD Management Service, explores how pharmaceutical manufacturers can navigate the revised ISO 14001 standard by strengthening existing management systems rather than starting from scratch.
IMA Group explores how intelligent control systems, product recovery technologies and brushless motors are helping pharmaceutical manufacturers reduce waste, lower energy consumption and improve production efficiency.
Barry O’Neill, EHS manager at Gaelic Laboratories, explains the role of pharma manufacturers in managing the spread of AMR, and the steps they should take to do this effectively.
CPHI has announced the launch of the CPHI Sustainability Summit, a new two-day event dedicated to advancing sustainability across the pharmaceutical value chain.
